Jupiter Neurosciences Files Q1 2025 10-Q

Ticker: JUNS · Form: 10-Q · Filed: May 15, 2025 · CIK: 1679628

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, quarterly-report

TL;DR

JUPITER NEUROSCIENCES (JUPITER) filed its Q1 2025 10-Q. No major financial changes reported yet.

AI Summary

Jupiter Neurosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Jupiter Orphan Therapeutics, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located in Jupiter, Florida.

Why It Matters

This filing provides investors with an update on Jupiter Neurosciences' financial performance and operational status for the first quarter of 2025, crucial for understanding the company's trajectory in the pharmaceutical sector.

Risk Assessment

Risk Level: low — The filing is a standard quarterly report with no immediately apparent significant financial distress or major strategic shifts indicated.

Key Numbers

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The conformed period of report is March 31, 2025.

What was Jupiter Neurosciences, Inc. formerly known as?

The company was formerly known as Jupiter Orphan Therapeutics, Inc., with a name change date of July 13, 2016.

Where is Jupiter Neurosciences, Inc. located?

The company's business and mailing address is 1001 NORTH US HWY 1, SUITE 504, JUPITER, FL 33477.

What is the Standard Industrial Classification (SIC) code for Jupiter Neurosciences, Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

When was this 10-Q form filed?

This 10-Q form was filed on May 15, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding JUPITER NEUROSCIENCES, INC. (JUNS).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing